Cross-talk between iron metabolism and intestinal inflammation
铁代谢与肠道炎症之间的串扰
基本信息
- 批准号:9172845
- 负责人:
- 金额:$ 42.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-15 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnemiaAnemia due to Chronic DisorderAnimalsBacteriaBindingBlood CirculationBone Morphogenetic ProteinsCell Culture TechniquesCell membraneColitisComplicationDevelopmentDietDiseaseDown-RegulationEnterocytesErythrocyte AgingErythropoiesisFoundationsFundingGene ExpressionGenesGoalsGrantHepaticHepatocyteHomeostasisHormonesIn VitroInflammationInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineInterleukin-1 betaInterleukin-10Interleukin-6InterventionIronKnockout MiceKnowledgeLeadLightLiverMediatingMetagenomicsMolecularNutrientOralOrganismPathogenesisPiroxicamPlayProbioticsQuality of lifeRecyclingRegulationRoleSTAT3 geneSerumSignal PathwaySignal TransductionSodium Dextran SulfateSourceStreptomycinSystemTestingUp-RegulationWild Type MouseWorkabsorptionbasecytokineeffective therapyfecal transplantationfollow-upgut microbiotahepcidinin vivoinsightinterestiron metabolismiron supplementmacrophagemembermetabolomicsmetagenomic sequencingmetal transporting protein 1microbial communitymicrobiotamonocytemouse modelnovelnovel therapeutic interventionprebioticspreventresearch studyresponsetissue culturetranscription factortreatment strategy
项目摘要
PROJECT SUMMARY
The anemia of inflammation (AI) is a frequent complication of inflammatory bowel disease (IBD) and is caused
by abnormally elevated expression of the hepatocyte-derived hormone hepcidin, the central regulator of
systemic iron homeostasis. Inflammation-associated increases in hepcidin expression lead to intracellular iron
sequestration, hypoferremia and compromised erythropoiesis. Effective treatment of AI requires detailed
knowledge of the mechanisms that up-regulate hepcidin in the context of inflammation. The goal of the
proposed studies is to elucidate these mechanisms using tissue culture approaches as well as mouse models
of IBD. In preliminary in vivo experiments, we have found that gut microbiota composition has a significant
influence on hepcidin expression during colitis and that this influence is associated with altered STAT3 activity
and STAT3-dependent gene expression in the liver. In addition, we have found from in vitro studies that
resident gut bacteria are able to induce the secretion of IL-1β by monocyte-macrophages, and that this
cytokine acts on hepatocytes to up-regulate hepcidin by a novel mechanism involving activation of the bone
morphogenetic protein (BMP) signaling pathway. Based on our findings, we hypothesize that the gut
microbiota has an important, previously unappreciated, effect on hepcidin expression during intestinal
inflammation, and that clarifying the molecular basis of this effect may lead to new strategies for manipulating
hepcidin levels. We will test this idea in experiments that will characterize 2 mechanisms by which the
microbiota influences hepcidin expression: (1) We will follow up on our preliminary in vivo observations to
clarify which aspects of STAT3-dependent hepcidin up-regulation are influenced by the microbiota. We will
also use metagenomic sequencing and metabolite profiling to shed light on the mechanisms that mediate the
effects of the microbiota on hepcidin expression. (2) Following up on our preliminary in vitro findings, we will
use a combination of in vitro and in vivo experiments to clarify how resident gut bacteria up-regulate hepcidin
via the novel IL-1β-mediated, BMP signaling-dependent mechanism. We will also determine the in vivo role of
this mechanism in colitis-associated hepcidin up-regulation. The results of our studies will increase
understanding of AI pathogenesis in IBD, and thus facilitate development of new treatments for this problem.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bobby Joseph Cherayil其他文献
Bobby Joseph Cherayil的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bobby Joseph Cherayil', 18)}}的其他基金
Effects of Salmonella infection on bone marrow macrophage progenitors
沙门氏菌感染对骨髓巨噬细胞祖细胞的影响
- 批准号:
10405563 - 财政年份:2021
- 资助金额:
$ 42.03万 - 项目类别:
Effects of Salmonella infection on bone marrow macrophage progenitors
沙门氏菌感染对骨髓巨噬细胞祖细胞的影响
- 批准号:
10302082 - 财政年份:2021
- 资助金额:
$ 42.03万 - 项目类别:
Cross-talk between iron metabolism and intestinal inflammation
铁代谢与肠道炎症之间的串扰
- 批准号:
8105669 - 财政年份:2011
- 资助金额:
$ 42.03万 - 项目类别:
Cross-talk between iron metabolism and intestinal inflammation
铁代谢与肠道炎症之间的串扰
- 批准号:
8280321 - 财政年份:2011
- 资助金额:
$ 42.03万 - 项目类别:
Cross-talk between iron metabolism and intestinal inflammation
铁代谢与肠道炎症之间的串扰
- 批准号:
9301440 - 财政年份:2011
- 资助金额:
$ 42.03万 - 项目类别:
Cross-talk between iron metabolism and intestinal inflammation
铁代谢与肠道炎症之间的串扰
- 批准号:
8670692 - 财政年份:2011
- 资助金额:
$ 42.03万 - 项目类别:
Cross-talk between iron metabolism and intestinal inflammation
铁代谢与肠道炎症之间的串扰
- 批准号:
8467671 - 财政年份:2011
- 资助金额:
$ 42.03万 - 项目类别:
Cross-talk between iron metabolism and intestinal inflammation
铁代谢与肠道炎症之间的串扰
- 批准号:
8077697 - 财政年份:2010
- 资助金额:
$ 42.03万 - 项目类别:
Mammalian metal transporters & Salmonella infection
哺乳动物金属转运蛋白
- 批准号:
6956535 - 财政年份:2005
- 资助金额:
$ 42.03万 - 项目类别:
Mammalian metal transporters & Salmonella infection
哺乳动物金属转运蛋白
- 批准号:
7140197 - 财政年份:2005
- 资助金额:
$ 42.03万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 42.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 42.03万 - 项目类别: